Strickland Emily, Arrey-Mbi Takor B
Internal Medicine, Madigan Army Medical Center, Tacoma, USA.
Medicine/Cardiology, Madigan Army Medical Center, Tacoma, USA.
Cureus. 2025 Aug 4;17(8):e89362. doi: 10.7759/cureus.89362. eCollection 2025 Aug.
Apical hypertrophic cardiomyopathy (ApHCM) is an uncommon, nonobstructive form of hypertrophic cardiomyopathy (HCM) that is associated with an increased risk of ventricular aneurysms, atrial fibrillation, heart failure, and cardiac death. In this case report, a 63-year-old male patient was found to have deeply negative T waves on electrocardiogram (EKG) during a routine preoperative evaluation in an outpatient internal medicine clinic. Imaging with echocardiography and cardiac magnetic resonance confirmed the diagnosis of ApHCM. Once the diagnosis was made, the patient underwent a thorough, guideline-directed evaluation for risk of sudden cardiac death (SCD), including ambulatory cardiac monitoring, cardiac MRI, and genetic testing. The patient continues to receive longitudinal care, including medical therapies with a beta-blocker, and periodic follow-up assessments of SCD risk.
心尖肥厚型心肌病（ApHCM）是肥厚型心肌病（HCM）的一种罕见的非梗阻性形式，与心室壁瘤、心房颤动、心力衰竭和心源性死亡风险增加相关。在本病例报告中，一名63岁男性患者在门诊内科诊所进行常规术前评估时，心电图（EKG）显示T波深倒置。超声心动图和心脏磁共振成像检查确诊为ApHCM。确诊后，对该患者进行了全面的、遵循指南的心脏性猝死（SCD）风险评估，包括动态心脏监测、心脏磁共振成像和基因检测。该患者继续接受长期护理，包括使用β受体阻滞剂进行药物治疗，以及定期进行SCD风险的随访评估。
